Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

David Guay, PhD
VP Innovation & Technology at Feldan Therapeutics
Speaker

Profile

David Guay is the VP Innovation & Technology at Feldan Therapeutics, a Canadian clinical-stage biotech company that specializes in the development of treatments based on the intracellular delivery of therapeutics. Dr. Guay received his PhD in molecular and cell biology from Laval University and conducted a postdoctoral fellowship in chemical engineering at McGill University. He joined Feldan Therapeutics in 2009 where he led the development and optimization of the Shuttle peptide technology that enables delivery of small molecules, PMOs and proteins to cells, airway epithelia, and basal cell carcinoma.

Agenda Sessions

  • Amphiphilic Shuttle Peptide Enables the Development of PMO-based Therapeutics to Treat Basal Cell Carcinoma and Muco-obstructive Lung Diseases

    , 10:45am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See David at TIDES USA: Oligonucleotide & Peptide Therapeutics